Clinical Trials Logo

Filter by:
NCT ID: NCT01427725 Completed - Clinical trials for Digestive System Diseases

Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency

Start date: September 2011
Phase:
Study type: Observational

This study aims at collecting the information related to the safety and effectiveness in the pancreatic exocrine insufficiency patients receiving the treatment with LipaCreon for a long term in order to evaluate the effective and safe use of LipaCreon.

NCT ID: NCT01427712 Completed - Cystic Fibrosis Clinical Trials

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Start date: August 2011
Phase:
Study type: Observational

This study aims at collecting the information related to the safety and effectiveness in the pancreatic exocrine insufficiency patients due to cystic fibrosis receiving the treatment with LipaCreon in order to evaluate the effective and safe use of LipaCreon.

NCT ID: NCT01427387 Completed - Healthy Clinical Trials

A Study to Evaluate Safety of Multiple Dose of ASP0456 in Healthy Subjects

Start date: June 2011
Phase: Phase 1
Study type: Interventional

A study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending dose of ASP0456 in non-elderly healthy subjects. Two dosing condition, pre-prandial and postprandial administrations, is compared.

NCT ID: NCT01425723 Completed - Severe Hemophilia B Clinical Trials

Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia B

B-YOND
Start date: December 8, 2011
Phase: Phase 3
Study type: Interventional

The primary objective of the study is to evaluate the long-term safety of rFIXFc in participants with hemophilia B. The secondary objective of this study is to evaluate the efficacy of rFIXFc in the prevention and treatment of bleeding episodes.

NCT ID: NCT01425632 Completed - Clinical trials for Perennial Allergic Rhinitis

A Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis

Start date: August 2011
Phase: Phase 3
Study type: Interventional

The objectives of this study are: to confirm the superiority of TAU-284 over placebo after two weeks of administration to pediatric patients with perennial allergic rhinitis, and to investigate the dose response, safety, and plasma concentrations of TAU-284.

NCT ID: NCT01424319 Completed - Clinical trials for Chronic Kidney Disease

Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With Atrasentan

Start date: August 2011
Phase: Phase 2
Study type: Interventional

Prospective, randomized, double-blind, placebo controlled, 12-week, multicenter study. The objective of the study is to evaluate the efficacy and safety of once daily administration of atrasentan tablets compared to placebo in reducing residual albuminuria in Japanese Type 2 diabetic patients with nephropathy who are treated with the maximum tolerated labeled dose for hypertension of a RAS (renin angiotensin system) inhibitor.

NCT ID: NCT01423994 Completed - Syncope Clinical Trials

Syncope: Pacing or Recording in the Later Years

Spritely
Start date: August 2011
Phase: Phase 4
Study type: Interventional

Syncope affects about 50% of Canadians, is the cause of 1 - 2% of all emergency room visits, and probably is responsible for CDN $250 million in health care spending each year. It is associated with decreased quality of life, trauma, loss of employment, and limitations in daily activities. It is a particular problem for older people, partly because of increased frailty, and partly because of a difficult differential diagnosis. One of the causes in older adults is intermittent complete heart block in the setting of bifascicular heart block, but they may also faint due to a variety of tachyarrhythmias, sick sinus syndrome, and several neurally mediated syncopes. Often treatment decisions should be made before the true cause is apparent.

NCT ID: NCT01423435 Completed - Healthy Adult Male Clinical Trials

Study to Compare Pharmacokinetic Profiles of TRK-100STP in Japanese, Chinese, and South Korean Non-elderly Healthy Adult Males

Start date: August 2011
Phase: Phase 1
Study type: Interventional

A study to evaluate the pharmacokinetics and safety of TRK-100STP in Japanese, Chinese, and South Korean non-elderly healthy adult males.

NCT ID: NCT01422434 Completed - Psoriasis Clinical Trials

LEO 90105 Ointment in Japanese Subjects With Psoriasis

Start date: July 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the efficacy of LEO 90105 ointment applied once daily with Dovonex® ointment applied twice daily and with Rinderon®-DP ointment applied once daily in Japanese subjects with psoriasis vulgaris.

NCT ID: NCT01422421 Completed - Hypertension Clinical Trials

Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery Disease

Start date: August 2011
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether intensive blood pressure and low density lipoprotein (LDL) cholesterol lowering could improve survival and cardiovascular outcome in Japanese diabetic patients with coronary artery disease and history of acute coronary syndrome.